Pre Transplantation Melanoma
Completed
- Conditions
- Malignant Melanoma
- Registration Number
- NCT04217382
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma.
There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet.
Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
- patient with an antecedent of melanoma before transplantation
- Not opposite to participate
Read More
Exclusion Criteria
- Under the age of 18
- patient under Guardianship
- patient not affiliated with a health system
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method survival time without melanoma recurrence at enrollment Delay in recurrence-free survival since diagnosis and since transplantation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
service de dermatologie - hopital Edouard Herriot
🇫🇷Lyon, Rhone, France